Compare IDEXX Laboratories, Inc. (IDXX) vs Zoom Video Communications, Inc. (ZM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs Zoom Video Communications, Inc. — how do they compare? IDEXX Laboratories, Inc. trades at $557.02 (market cap $44.48B), while Zoom Video Communications, Inc. trades at $90.4 (market cap $26.66B). The key difference: IDEXX Laboratories, Inc. is the larger of the two by market cap, and Zoom Video Communications, Inc. is trading nearer its 52-week high, IDEXX Laboratories, Inc. nearer its low. Which is the better fit depends on your goals.
| IDXX | ZM | |
|---|---|---|
Market Cap | $44.48B | $26.66B |
Sector | Health | Technology |
52-Week High | $766.68 | $111.88 |
52-Week Low | $520.87 | $69.77 |
Enterprise Value | $45.38B | $19.00B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDXX trades at $563.79, down 0.64% today but maintains strong fundamental momentum with consistent earnings beats and robust profitability. The stock shows bullish technical signals with support at $563 and resistance at $572, while valuation metrics remain elevated. Recent Q1 2026 results exceeded expectations with EPS of $3.47 versus $3.41 estimates, supporting the company's leadership in veterinary diagnostics.
Outlook remains positive given strong analyst support (59% buy ratings) and innovation pipeline, though premium valuations and competitive pressures present risks. Revenue growth trajectory and expanding margins provide fundamental support for continued upside potential in the pet healthcare sector.
Zoom Communications (ZM) trades at $91.04, down 0.1% on the day, with a bullish technical signal from moving averages and support at $90. The company reported Q1 2026 EPS of $1.55, beating expectations, and maintains strong profitability with a net income margin of 42.0%. Recent news highlights AI product launches and a $1 billion buyback authorization, while analyst consensus price target sits at $118.79.
The outlook for ZM is cautiously optimistic, with upside potential driven by AI integration and solid cash flow, but risks include competitive pressure from Microsoft and Google, insider selling, and fluctuating cash flow trends. Wall Street sentiment is mixed, with 39% of analysts rating it Buy amid moderate growth projections.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About Zoom Video Communications, Inc.
Zoom Video Communications, Inc. develops a people-centric cloud service that transforms real-time collaboration experience. The Company offers unified meeting experience, a cloud service that provides a 3-in-1 meeting platform with HD video conferencing, mobility, and web meetings. Zoom Video Communications serves customers worldwide.
Read more on ZM →
